Ma, J., Yang, Y., Zhang, J., Meng, H., Ling, X., Wang, X., Xin, Y., Jiang, H., Zhang, L., Fang, C., Liang, H., Zhu, J., Qin, X., Lei, J. (2025). Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16139